TIM-3 therapy for Alzheimer's is emerging as a promising approach in the realm of Alzheimer's disease treatment, leveraging immune system checkpoint mechanisms traditionally used in cancer therapies.Recent studies have shown that inhibiting TIM-3 enables microglia, the brain's immune cells, to effectively clear amyloid plaques, leading to notable improvements in cognitive function among treated mice.